Danimer Scientific announces $15M registered direct offering

Danimer Scientific “announced that it has entered into a definitive agreement for the purchase and sale of 15,000,000 shares of common stock at a purchase price of $1.00 per share and accompanying warrants to purchase up to an aggregate of 15,000,000 shares of common stock in a registered direct offering. The warrants have an exercise price of $1.33 per share, will be exercisable commencing six months from the date of issuance and will expire five and one-half years following the date of issuance. The closing of the offering is expected to occur on or about March 25, 2024, subject to the satisfaction of customary closing conditions. Roth Capital Partners is acting as the exclusive placement agent for the offering.”